PRUDENTIAL FINANCIAL INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$8,058,000
+118.4%
173,911
+14.9%
0.01%
+100.0%
Q1 2019$3,689,000
-35.1%
151,317
-62.8%
0.01%
-40.0%
Q4 2018$5,686,000
+51.7%
406,847
+65.0%
0.01%
+66.7%
Q3 2018$3,749,000
+13.5%
246,627
+25.3%
0.01%
+20.0%
Q2 2018$3,303,000
+2.7%
196,837
-0.1%
0.01%0.0%
Q1 2018$3,216,000
+1132.2%
197,047
+868.0%
0.01%
Q4 2017$261,000
+10.1%
20,357
+5.8%
0.00%
Q3 2017$237,000
+49.1%
19,247
+1.5%
0.00%
Q2 2017$159,000
+2.6%
18,957
+9.1%
0.00%
Q1 2017$155,000
+4.7%
17,377
+3.5%
0.00%
Q4 2016$148,000
+45.1%
16,787
+10.6%
0.00%
Q3 2016$102,000
+100.0%
15,177
+6.5%
0.00%
Q2 2016$51,000
+37.8%
14,257
+12.6%
0.00%
Q1 2016$37,000
-36.2%
12,657
-8.0%
0.00%
Q4 2015$58,000
-7.9%
13,7570.0%0.00%
Q3 2015$63,000
-36.4%
13,7570.0%0.00%
Q2 2015$99,000
-2.9%
13,757
-0.7%
0.00%
Q1 2015$102,000
+92.5%
13,857
+23.1%
0.00%
Q4 2014$53,000
+29.3%
11,257
-0.9%
0.00%
Q3 2014$41,000
-59.4%
11,357
-48.9%
0.00%
Q2 2014$101,000
+90.6%
22,226
+95.7%
0.00%
Q1 2014$53,000
-8.6%
11,357
-1.7%
0.00%
Q4 2013$58,000
-19.4%
11,5570.0%0.00%
Q3 2013$72,000
+44.0%
11,557
+4.5%
0.00%
Q2 2013$50,00011,0570.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders